2014 participants
Samuel Tingle
Pancreatic cancer is a devastating disease with a dismal prognosis. Recent lab research has suggested cells surrounding cancers interact with the tumour to stimulate growth. This retrospective study examines whether certain medications that target these interactions lead to improved outcomes. The bulk of my data collection will be from patient notes. I will focus on the use of blood pressure lowering drugs and anti-inflammatory drugs (aspirin). Information on other prognostic factors will be gathered, so that I can allow for these in my analysis. I will then observe whether these drugs result in improved survival in this group of patients.
Funding source: Newcastle University